Regen BioPharma Inc (RGBP) › Net IncomeRegen BioPharma Inc (RGBP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$355.0K2014: -$756.4K2015: -$11.20M2016: -$7.75M2017: -$5.84M2018: -$4.72M2019: -$2.62M2020: $3.41M2021: -$6.77M2022: $2.44M2023: $1.16M2024: -$668.3K2025: -$1.27M-$1.27M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$1.27M-90.7%2024-$668.3K-157.8%2023$1.16M-52.7%2022$2.44M+136.1%2021-$6.77M-298.1%2020$3.41M+230.2%2019-$2.62M+44.4%2018-$4.72M+19.2%2017-$5.84M+24.7%2016-$7.75M+30.8%2015-$11.20M-1380.1%2014-$756.4K-113.0%2013-$355.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share